Skip to content

Clinical trials

Terminated Phase 2 Parkinson Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Parkinson Disease Phase: Phase 2 Status: Terminated Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20042
20061
20072
20084
20091
20101
20111
20133
20151
20163
20173
20182
20193
20201
20211
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated35

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eisai Inc.3
Pfizer3
Bayer2
University Health Network, Toronto2
ACADIA Pharmaceuticals Inc.1
Aaron Ritter, MD1
Abbott Products1
Alexza Pharmaceuticals, Inc.1
Azienda Ospedaliera Cardinale G. Panico1
Biogen1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Parkinson Disease35
Dyskinesias5
Movement Disorders2
Parkinsonian Disorders2
Alzheimer Disease1
Basal Ganglia Diseases1
Brain Diseases1
Central Nervous System Diseases1
Constipation1
Dyskinesia, Drug-Induced1

Trials

Showing 1 to 25 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.